Brief: Spectracures Signs LoI With Cheplapharm

SpectraCure AB (publ)

07/12/2022 10:13

Dec 7 (Reuters) - SpectraCure AB (publ)  SPEC.ST :
    * SPECTRACURES SIGNS LETTER OF INTENT WITH CHEPLAPHARM
    * SIGNED A LETTER OF INTENT WITH GERMAN PHARMA COMPANY
CHEPLAPHARM
TO SECURE GLOBAL SUPPLY OF REQUIRED ACTIVE PRODUCT INGREDIENT
    * TAKEN STRATEGIC DECISION TO BECOME MARKET AUTHORIZATION
HOLDER
OF PHOTOSENSITIZING DRUG USED AS A PART OF PHOTODYNAMIC THERAPY
(PDT)
    * NOT ONLY WILL SELL TREATMENT PLATFORM Q-PRO, BUT ALSO
WILL,
UNDER ITS OWN TRADEMARK, MARKET AND SELL DRUG REQUIRED TO CARRY
OUT TREATMENT

Source text for Eikon:  ID:nWkr8vFjCG 
Further company coverage:  SPEC.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))